The Hyderabad based Bharat Biotech International Private Limited manufactured COVAXIN has been found effective against the new Delta Plus variant of the Wuhan virus. The latest development regarding the Novel…
The National Technical Advisory Group on Immunisation (NTAGI) recommended a gap of 12 to 16 weeks between the two doses of Covisheild. On the 13th of May, the NTAGI studied…
The Uddhav Thackeray and B.S. Yeddyurappa led Maharashtra and Karnataka governments, respectively, halted the Novel Coronavirus (COVID-19) vaccination drive for individuals between 18 to 44 years old temporarily. The decision…
After the Serum Institute of India (SII,) the Hyderabad based Bharat Biotech International Private Limited also fixed the prices for India made vaccine for the Novel Coronavirus COVAXIN. On the…
On the 1st of March 2021, the Prime Minister of India took the first dose of the Novel Coronavirus or COVID-19 vaccination. Prime Minister Narendra Modi took his COVID-19 vaccine…
The Indian Government is all set to send the Novel Coronavirus or COVID-19 vaccine to 7 more countries. Recently from the 20th of January, India send COVID-19 vaccine to Nepal,…
On the 22nd of January, the Hyderabad based Bharat Biotech International Private Limited announced to administer 2nd dose of COVAXIN to 13,000 volunteers. The second dose of the Novel Coronavirus…
Balram Bhargava, the Chief of the Indian Council of Medical Research (ICMR) asked the Bharat Biotech International Private Limited to take consent from volunteers. On the 5th of January, the…
